These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 17885490

  • 1. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
    Wong KK, Lu KH, Malpica A, Bodurka DC, Shvartsman HS, Schmandt RE, Thornton AD, Deavers MT, Silva EG, Gershenson DM.
    Int J Gynecol Pathol; 2007 Oct; 26(4):404-9. PubMed ID: 17885490
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 6. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
    Lindgren P, Bäckström T, Mählck CG, Ridderheim M, Cajander S.
    Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of estrogen receptor and progesterone receptor status in young Chinese ovarian carcinoma patients.
    Yang XY, Xi MR, Yang KX, Yu H.
    Gynecol Oncol; 2009 Apr; 113(1):99-104. PubMed ID: 19178934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers.
    Buchynska LG, Iurchenko NP, Grinkevych VM, Nesina IP, Chekhun SV, Svintsitsky VS.
    Exp Oncol; 2009 Mar; 31(1):48-51. PubMed ID: 19300417
    [Abstract] [Full Text] [Related]

  • 10. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A.
    Cancer; 2003 Sep 01; 98(5):1055-60. PubMed ID: 12942575
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 01; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 12. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K.
    Anticancer Res; 2007 Dec 01; 27(4A):2027-33. PubMed ID: 17649817
    [Abstract] [Full Text] [Related]

  • 13. The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables.
    Sylvia MT, Kumar S, Dasari P.
    Indian J Pathol Microbiol; 2012 Dec 01; 55(1):33-7. PubMed ID: 22499297
    [Abstract] [Full Text] [Related]

  • 14. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R, Che M, Khalifeh I, Malone JM, Morris R, Lawrence WD, Munkarah AR.
    Cancer; 2003 Oct 01; 98(7):1423-9. PubMed ID: 14508829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.
    Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM.
    Clin Cancer Res; 2004 Oct 01; 10(19):6432-6. PubMed ID: 15475429
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer.
    Daponte A, Kostopoulou E, Papandreou CN, Daliani DD, Minas M, Koukoulis G, Messinis IE.
    Anticancer Res; 2008 Oct 01; 28(3B):1905-10. PubMed ID: 18630479
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
    Stawerski P, Wagrowska-Danilewicz M, Stasikowska O, Gottwald L, Danilewicz M.
    Pol J Pathol; 2008 Oct 01; 59(1):27-32. PubMed ID: 18655368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.